Led · Equity · Mar 2026

AppWork develops property-technology solutions aimed at tackling maintenance challenges in multifamily housing. The company has a presence in St. Petersburg and has been described as fast-growing. Over the past year it reported approximately 200% revenue growth. The firm recently raised $7 million in new funding as investors increased their support. The article did not provide specific revenue figures, user counts, or detailed product roadmaps. Additional operational or financial metrics were not disclosed in the coverage.

Participated · Equity · Sep 2024

ACTO offers an AI-first IFE platform focused on closing gaps in HCP omnichannel engagement for life sciences commercial teams. Its product roadmap centers on the LAICA suite, announced in 2022, and integrated Generative AI capabilities. Planned GenAI features include field rep real-time knowledge assistance, simulated rep–manager roleplay and coaching, commercial learning content creation assistance, and commercial leader field insight assistance. The company announced a dedicated US$10M investment into GenAI to accelerate those capabilities. Funding for this effort comes from ACTO’s venture capital backers alongside public and cloud partners, and the company is piloting real-world use cases with customers via the AWS Jumpstart Program. Executives and investors frame ACTO as an early AI-focused category leader on the commercial side of life sciences, citing work that began as early as 2019. ACTO provides an AI-powered omnichannel learning and enablement SaaS platform that helps global life‑sciences companies educate and engage field teams and learners across the care continuum. Commercial and clinical leaders use ACTO to deliver unified educational experiences and sales enablement at scale. The company maintains a network of partnerships with content agencies, data providers, and technology companies to build an ecosystem for life sciences. ACTO recently introduced a conversational assistant, LAICA™, as part of its product roadmap to make commercial learning easier and more engaging. The company is experiencing robust user and revenue growth, reporting a 500% increase in annual recurring revenue since 2018 and total invested capital exceeding US$30 million. Proceeds from its latest financing will be used to accelerate growth, expand capabilities, and pursue business and partnership opportunities. ACTO builds an AI-powered mobile platform that educates and supports stakeholders in life sciences, enabling training, content delivery, and sales enablement. The platform offers self-paced modules called ActionPacks containing multimedia, quizzes, 3D content, authoring tools, and event engagement features. ACTO has launched conversational AI capabilities that surface information about drugs and medical devices to support doctors, nurses, and other providers. Managers can certify reps with digital signatures and PDF certificates, run assessments, and deliver AI-personalized notifications and reference guides. The platform includes deep search, multi-channel integrations, permissioning, tracked mail/text links, and CRM integrations that generate reports by individual, team, and territory. ACTO says tens of thousands of reps rely on it across 50 life sciences companies, including AstraZeneca, Teleflex, and Philips Respironics. The company closed an $11.5 million funding round to bolster these capabilities and accelerate digital engagement.

Led · Series B · Nov 2023

Kahuna offers a flagship skills management platform that digitizes granular skills data to validate, track, and analyze workforce capabilities. The platform replaces manual Excel tracking and traditional HRIS approaches, enabling organizations to identify skills gaps and deliver targeted development. Kahuna serves leading Fortune 500 customers across energy, manufacturing, field service, and world‑renowned healthcare systems, demonstrating scalability for complex operational needs. The company announced a $21 million Series B to accelerate growth. Kahuna plans to use the funding to accelerate product development and innovation, expand teams across sales, marketing, product development, customer success, and engineering, and increase operational capabilities to support global customers. The focus is enabling resilient operations, improved productivity, and skills‑based strategies for frontline workers.

Led · Equity · Mar 2023

VETRO builds a map-based SaaS platform that serves as an open, precise system of record for fiber assets, aiming to simplify digitization, data visualization, and management of networks. The platform is described as easier to use and more powerful than traditional tools for network operators and ISPs. Since early 2021 the company has seen accelerating growth in bookings, revenue, and customer expansion, with network operator customers in 46 states and 25 countries. VETRO positions its product to support the massive fiber build-out driven by programs like BEAD and growing private investment. The company plans to use new resources to fuel global expansion, accelerate product innovation for its open platform, and build out its Fiber Management Platform offerings. VETRO also intends to embark on initiatives across software engineering, go-to-market, and customer engagement to support continued growth.

Led · Equity · Nov 2022

SocialClimb provides a Software-as-a-Service healthcare marketing platform that helps providers collect reviews, improve rankings, and deliver targeted reputation ads using deep analytics. The platform is designed to help healthcare organizations dominate local search and attract the most profitable patients for practices of varying sizes. Since founding, SocialClimb has interacted with millions of patients per month to drive patient acquisition for practices and physicians. Led by CEO Ty Allen, the company serves a range of providers and intends to expand its reach into larger practices and hospital groups. The company plans to use new capital to drive additional product development and market expansion. The recent fundraising reflects an effort to scale product capabilities and enter larger healthcare customers. SocialClimb is a SaaS patient acquisition platform that helps doctors, practices and hospitals target and attract patients through reputation management, targeted ads and analytics. Its 1-to-1 marketing platform pairs social media with big data and targeted digital marketing to automate patient acquisition and measure ROI. The platform integrates deeply with practice management systems and uses predictive analytics to identify and target ideal patients. SocialClimb says it services thousands of physicians and practices across the nation to improve online reputation and local search rankings. The company plans to use the new funding to further develop its technologies and expand into additional specialties and more hospital groups. Leadership highlights the goal of helping practices dominate competitive markets and fill schedules with profitable patients.